Primary Care Enhanced Services
Overview
Summary, notice description and lot information
NHS Lincolnshire Integrated Care Board has announced an intention to award a contract for Primary Care Enhanced Services under the Health Care Services (Provider Selection Regime) Regulations 2023. The services include phlebotomy, specialised drug monitoring, safeguarding, and more. The procurement process utilises a direct award method without prior publication, specifically under PSR regulations, and the awarding of this contract is not governed by the Public Contracts Regulations 2015.
The contract, valued at £69,488, is intended for a duration from 1st April 2025 to 31st March 2026, serving the UKF3 region. The standstill period ends on 12th September 2025, which is the deadline for submitting representations. This procurement presents a business growth opportunity for general-practice service providers, particularly those that can offer innovative solutions while maintaining high standards in quality and value.
Small to medium-sized enterprises (SMEs) with expertise in healthcare services, particularly in the areas outlined, are well-suited to compete in this sector, benefiting from the stable contractual relationship and the potential to improve healthcare outcomes for communities. Given the focus on integration and sustainability, businesses that excel in collaborative approaches and service expansion would find this tender especially advantageous.
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Pessaries - DOAC - Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding - DVT Assessment & Management including D-Dimer Testing
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Pessaries - DOAC - Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding - DVT Assessment & Management including D-Dimer Testing The contract duration is from 1st April 2025 to 31st March 2026 and the expected value of the activity for the lifetime of the contract is PS69,488. The provider is an existing provider and the services are existing services.
Procurement Classification
Notice type, method, and CPV codes
Contract Values
Financial information and value estimates
Contract duration information not available.
Key Dates
Publication, submission, and award timeline
Notice Status
Current status of tender, lots, awards, and contracts
Contracting Authority
Buyer organisation and contact details
Awarded Supplier
Supplier who was awarded this contract
Documents & Links
External resources and data downloads
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector.
Need help with your tender submission?
Our expert team can help you prepare a winning bid. Get professional support from CareSync Experts.
Get in touch with our team at Care Sync Experts today for a consultation.
Email: hello@caresyncexperts.co.uk
Phone: 0333 577 0877
Contact UsBidding for contracts like this
Other tenders in North Kesteven
- Northamptonshire Children's Trust - Expression of Interest (EOI) - Strategic Partner to Innovate with NCT to Develop Existing and New Services to Contribute to Making a Sustainable Improvement to the Lives of Children, Young People and Families in West Northamptonshire
- Integrated Advocacy Service in Derby
- Integrated Advocacy and Advice Service in Derby
- Palliative and End of Life Hospice and Community Service in Gedling
- CVF0509 - Integrated Sexual Health Services in Leicester
- Provision of Long-Acting Reversible Contraception (LARC) through primary care in West Northamptonshire in West Northamptonshire